ÂÜÀòÂÒÂ×

Victor Prikhodko is an experienced professional currently serving as the Portfolio and Platform Lead for TB and HIV R&D at the Bill & Melinda Gates Foundation. In this role, Victor develops portfolio execution plans, collaborates with foundation partners, and manages clinical development programs, while also overseeing risk assessment and project management processes. Additional experience includes serving as Executive Advisor at Myosin Therapeutics Inc. and Associate Director of Global Program Management at Novavax, where Victor managed strategic alliances leading to large-scale vaccine production. Previous roles include Principal and Senior Business Advisor at the National Institute on Drug Abuse, Project Manager at Advanced Bioscience Laboratories, and Senior Research Specialist at Aeras. Victor holds an MBA from The Johns Hopkins University - Carey Business School and a degree in Microbiology from the University of Maryland.